In this issue of Blood, Myllymäki et al1 evaluated the role of pretransplant leukocyte telomere length (LTL) on survival outcomes in patients with myelodysplastic syndrome (MDS). The authors found associations between recipient short LTL and poor overall survival and high risk of nonrelapse mortality (NRM) after unrelated donor hematopoietic cell transplant (HCT).
CITATION STYLE
Gadalla, S. M. (2020, December 24). Telomere length in hematopoietic cell transplant. Blood. American Society of Hematology. https://doi.org/10.1182/blood.2020008547
Mendeley helps you to discover research relevant for your work.